NeuroCure’s goal is to transfer insights gained from basic science to clinical application and to develop new therapies and diagnostic approaches. Through the closer dovetailing of outstanding basic and clinical research with expertise in conducting clinical studies, NeuroCure contributes to improving treatment for patients with neurological diseases (e.g., stroke, multiple sclerosis, Alzheimer’s disease and dementia, movement disorders and epilepsy) and psychiatric disorders (e.g., autism, depression, schizophrenia and addictions).
In order to provide patients with the fastest possible access to new therapeutic and diagnostic options, the NeuroCure Clinical Research Center (NCRC) was founded in 2008. NCRC researchers are currently active in the areas of cerebrovascular diseases, neuroinflammation, neurodegeneration, and disturbances of functional network structures. Clinical studies on the following diseases are conducted in the NCRC:
- Multiple sclerosis
- Alzheimer’s disease and dementia
- Developmental disturbances of the nervous system
For more information please visit the NCRC webpage.